Literature DB >> 22834658

Effects of antipsychotic polypharmacy on side-effects and concurrent use of medications in schizophrenic outpatients.

Yasuhiko Hashimoto1, Junji Uno, Takaichi Miwa, Masaaki Kurihara, Hiroaki Tanifuji, Masami Tensho.   

Abstract

AIMS: Medical therapy is the cornerstone of schizophrenia, but >50% of patients do not adhere to medication regimens. In previous reports, the reasons for non-adherence were assessed only by medical staff. We think that patients have specific reasons for non-adherence. We researched whether there was an association between patients' subjective opinions and the number of antipsychotics used.
METHODS: A self-rating questionnaire survey was conducted on 252 outpatients with schizophrenia at five psychiatric hospitals in Japan. Based on patients' subjective opinions, we retrospectively analyzed the patients' medications: the number of antipsychotics, concurrently used agents, and dosages of antipsychotics.
RESULTS: There was no significant difference regarding attitudes toward medication between monotherapy and polypharmacy. The most common reason for not taking medications was 'I sometimes forget' followed by 'side-effects'. Of the latter, weight gain was the most common, and dry mouth (P < 0.05) and sexual dysfunction (P < 0.01) were significantly higher in polypharmacy. The dosages of antipsychotics (P < 0.01), concurrent use of anti-Parkinsonian agents (P < 0.01), and the number of side-effects (P < 0.01) were also higher in polypharmacy.
CONCLUSIONS: Patients had good attitudes toward medication but a higher prevalence of side-effects was seen in polypharmacy of antipsychotics. Hence, monotherapy may be a more appropriate prescription with respect to side-effects. By using monotherapy, patients may reduce feelings of discomfort due to side-effects.
© 2012 The Authors. Psychiatry and Clinical Neurosciences © 2012 Japanese Society of Psychiatry and Neurology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22834658     DOI: 10.1111/j.1440-1819.2012.02376.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  11 in total

Review 1.  Management of sexual dysfunction due to antipsychotic drug therapy.

Authors:  Hannah M Schmidt; Mathias Hagen; Levente Kriston; Karla Soares-Weiser; Nicola Maayan; Michael M Berner
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

2.  Poor Oral Health in Patients with Schizophrenia: a Meta-Analysis of Case-Control Studies.

Authors:  Xiao-Ni Sun; Jian-Bo Zhou; Na Li
Journal:  Psychiatr Q       Date:  2021-03

3.  Saliva secretion disorder in a schizophrenic patient - a problem in dental and psychiatric treatment: a case report.

Authors:  Danuta Maria Moś
Journal:  Ann Gen Psychiatry       Date:  2015-03-10       Impact factor: 3.455

4.  Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia.

Authors:  Masakazu Hatano; Hiroyuki Kamei; Azusa Kato; Ippei Takeuchi; Manako Hanya; Junji Uno; Shigeki Yamada; Kiyoshi Fujita; Nakao Iwata
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-05-31       Impact factor: 2.582

5.  Antipsychotic Use Pattern in Schizophrenia Outpatients: Correlates of Polypharmacy.

Authors:  Esra Yazici; Ali S Cilli; Ahmet B Yazici; Hayriye Baysan; Mustafa Ince; Sukriye Bosgelmez; Serkan Bilgic; Betul Aslan; Atila Erol
Journal:  Clin Pract Epidemiol Ment Health       Date:  2017-08-11

6.  Prevalence and management practice of first generation antipsychotics induced side effects among schizophrenic patients at Amanuel Mental Specialized Hospital, central Ethiopia: cross-sectional study.

Authors:  Yirgalem Shewakena Wubeshet; Oumer Sada Mohammed; Tigestu Alemu Desse
Journal:  BMC Psychiatry       Date:  2019-01-18       Impact factor: 3.630

7.  Evaluation of oral antipsychotic supplementation of select second-generation long-acting injectable antipsychotics in an acute-care psychiatric setting.

Authors:  Jennifer N Alastanos; Chris Paxos; Jessica Emshoff
Journal:  Ment Health Clin       Date:  2019-01-04

8.  The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample.

Authors:  Christian Farrell; Johann Brink
Journal:  Front Psychiatry       Date:  2020-04-17       Impact factor: 4.157

9.  The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective.

Authors:  Stephan Hjorth
Journal:  Front Psychiatry       Date:  2021-11-24       Impact factor: 4.157

10.  Periodontal disease and effects of antipsychotic medications in patients newly diagnosed with schizophrenia: a population-based retrospective cohort.

Authors:  Kai-Fang Hu; Pei-Shan Ho; Yu-Hsiang Chou; Jui-Hsiu Tsai; Chung-Hung Richard Lin; Hung-Yi Chuang
Journal:  Epidemiol Psychiatr Sci       Date:  2019-09-17       Impact factor: 6.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.